Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Tetrahexylammonium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A1 | O15245 | 3/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.59 |
| ▸ | TP53 | P04637 | 1/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.59 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.57 |
| ▸ | DNM1 | Q05193 | 6/20 | 0.54 |
| ▸ | LSS | P48449 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL11119601 | 1.00 | SLC22A1 (0.62) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| Sulfuric Acid SCHEMBL1697123 | 1.00 | SLC22A1 (0.62) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| Sulfuric Acid SCHEMBL4372101 | 1.00 | SLC22A1 (0.62) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| Sulfuric Acid SCHEMBL9792104 | 0.98 | SLC22A1 (0.59) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| Sulfuric Acid SCHEMBL11840392 | 0.98 | SLC22A1 (0.59) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| Tetrahexylammonium SCHEMBL3641189 | 0.98 | SLC22A1 (0.59) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| Sulfuric Acid SCHEMBL11534969 | 0.98 | SLC22A1 (0.59) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| Tetrapentylammonium SCHEMBL6261133 | 0.98 | SLC22A1 (0.60) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| Sulfuric Acid SCHEMBL6260571 | 0.96 | SLC22A1 (0.56) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| Sulfuric Acid SCHEMBL6260172 | 0.96 | SLC22A1 (0.56) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 283 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119823109-A | An electrochromic material electrochromic composition and electrochromic device | 吉林大学 | 2025-04-15 | — | — | CN | claimed |
| CN-119757606-A | Method for detecting triethyl phosphonoformate in sodium phosphonoformate | 安徽恒星制药有限公司 | 2025-04-04 | — | — | CN | claimed |
| CN-119510645-A | Method for detecting content of zoledronic acid concentrated solution for injection | 海南葫芦娃药业集团股份有限公司 | 2025-02-25 | — | — | CN | claimed |
| US-20250043039-A1 | HALOGEN RECOVERY WITH OXIDANT AND PHASE TRANSFER CATALYST IN A PROCESS FOR HALOGENATING UNSATURATED ISOOLEFIN COPOLYMER | ARLANXEO SINGAPORE PTE. LTD. (SG) | 2025-02-06 | — | — | US | claimed |
| CN-119310209-A | Analysis method of related substances of zoledronic acid concentrated solution for injection | 海南葫芦娃药业集团股份有限公司 | 2025-01-14 | — | — | CN | claimed |
| EP-4448595-A1 | HALOGEN RECOVERY WITH OXIDANT AND PHASE TRANSFER CATALYST IN A PROCESS FOR HALOGENATING UNSATURATED ISOOLEFIN COPOLYMER | Arlanxeo Singapore Pte. Ltd. (SG) | 2024-10-23 | — | — | EP | claimed |
| CN-118382650-A | Recovery of halogen during halogenation of unsaturated isoolefin copolymers using an oxidant and a phase transfer catalyst | 阿朗新科新加坡私人有限公司 | 2024-07-23 | — | — | CN | claimed |
| WO-2024081696-A2 | COMPOSITIONS CONTAINING PHASE CHANGE MATERIALS, METHODS FOR FORMING OBJECTS USING THE SAME, AND METHOD FOR USING THE SAME | PHASE CHANGE ENERGY SOLUTIONS, INC. (US) | 2024-04-18 | — | — | WO | claimed |
| CN-111117594-B | Electrochromic material and electrochromic device based on dynamic metal-ligand complexation | 吉林大学 | 2024-03-26 | — | — | CN | claimed |
| WO-2023233774-A1 | NOVEL DIALLYL-CONTAINING FLUOROPOLYETHER COMPOUND AND METHOD FOR PRODUCING SAME | ユニマテック株式会社 | 2023-12-07 | — | — | WO | claimed |
| WO-2016142296-A1 | POLYMERIZABLE DENTAL MATERIAL HAVING A PHASE TRANSFER CATALYST | KETTENBACH GMBH & CO. KG (DE) | 2016-09-15 | — | — | WO | claimed |
| US-20160262987-A1 | Polymerizable Dental Material With a Phase Transfer Catalyst | KETTENBACH GMBH & CO. KG (DE) | 2016-09-15 | — | — | US | claimed |
| US-8618335-B2 | Process for preparing aromatic aldehyde compound | UBE INDUSTRIES LTD. (JP) | 2013-12-31 | — | — | US | claimed |
| US-7541312-B2 | Porous carbons from carbohydrates | TDA RESEARCH, INC. (US) | 2009-06-02 | — | — | US | claimed |
| US-7153635-B1 | Thermally developable materials processable at lower temperatures | EASTMAN KODAK COMPANY (US) | 2006-12-26 | — | — | US | claimed |
| US-20050207962-A1 | Porous carbons from carbohydrates | TDA RESEARCH, INC. (US) | 2005-09-22 | — | — | US | claimed |
| EP-0743574-B1 | Migration imaging members | XEROX CORP (US) | 2000-12-27 | — | — | EP | claimed |
| EP-0743573-B1 | Method for obtaining image contrast migration imaging members | XEROX CORP (US) | 2000-09-06 | — | — | EP | claimed |
| US-5683793-A | Ink jet transparencies | XEROX CORPORATION (US) | 1997-11-04 | — | — | US | claimed |
| US-4849531-A | Process for the preparation of 2,3-epoxyamides | BAYER AKTIENGESELLSCHAFT (DE) | 1989-07-18 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160262987-A1 | Polymerizable Dental Material With a Phase Transfer Catalyst | PRDX4, SMOX, PRDX2 | SLC22A1 924/4885ALDH1A1 1564/4885TP53 3325/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.